To clarify whether heme oxygenase-l (HO-I) pro tein plays a protective role against cerebral ischemia, we in vestigated the effects of an HO inhibitor (tin mesoporphyrin IX [SnMP] three doses of 30 j,Lmol/kg, intraperitoneally) and an HO inducer (hemin, three doses of 30 j,Lmol/kg, intraperito neally) on the pathologic outcome and on the immunohisto chemical reaction for HO-I after 20-minute transient forebrain ischemia followed by 3-day reperfusion in rats. Hemin signifi cantly increased viable neurons in the cortex (compared to the SnMP-treated group, P < .05) and striatum (compared to the saline-treated group at P < .0 I and SnMP-treated group at P < Abbreviations used: CO, carbon monoxide; GFAP, glial fibrillary acidic protein; HO, heme oxygenase; NO, nitric oxide; NOS, nitric oxide synthase; SnMP, tin mesoporphyrin IX; ZnPP, zinc protoporphy rin IX. 559 . 05), and intense HO-I immunoreactivity was observed in cor tex and striatum, whereas the administration of SnMP tended to decrease viable neurons in the parietal cortex. In contrast, nei ther hemin nor SnMP affected the pathologic outcome in the CAl and CA3 hippocampi, in which HO-I immunoreactivity was weak. These results suggest that induction of HO-l protein may contribute to cellular defense against ischemic damage in brain regions where potential ability to synthesize HO-I is retained in ischemia. Key Words: Carbon monoxide Forebrain ischemia-Heme oxygenase-Hem in-Tin meso porphyrin IX.
While most of protein synthesis is inhibited in cerebral ischemia (Kiessling et aI., 1986; Mies et aI., 1991 ) , spe cific stress proteins are induced, including the heat shock proteins (Tomioka et aI., 1993) , glutathione peroxidase (Takizawa et aI., 1994) , ornithine decarboxylase (Milller et aI., 1991) , and others. Heme oxygenase (HO)-1 , an inducible form of HO, is well known as the 32-kd heat shock protein which is induced by various stimuli, in cluding heat shock, metals, and oxidative stress (Dwyer et aI., 1992; Maines, 1991, 1992; Keyse and Tyrrell, 1989) . HO catalyzes the rate-limiting step in heme catabolism, generating free iron, carbon monoxide (CO) and biliverdin, which is rapidly reduced to bilirubin by biliverdin reductase (Kikuchi and Yoshida, 1983) .
Biliverdin and bilirubin have a strong cellular antioxi dant activity and may contribute to cellular defenses against oxidative stress (Stocker et aI., 1987a (Stocker et aI., , 1987b . CO that activates guanylyl cyclase acts as a putative neural messenger (Verma et aI., 1993; Dawson and Snyder, 1994) , inhibits nitric oxide synthase (NOS) ac tivity in rat cerebellum (White and Marietta, 1992) , and modulates the NO-cGMP signaling system (Ingi et aI., 1996) . CO has the ability to relax smooth muscle and to block platelet aggregation (Verma et aI., 1993) . Further more, the induction of HO inhibits some of the enzymes involved in arachidonic acid metabolism (Martasek et aI., 1991) . These findings indicate that HO plays a pro tective role against ischemia. In contrast, it has been reported that the inhibition of HO activity reduced infarct size and edema accumulation in rat focal ischemia (Kadoya et aI., 1995) and blocked the effect of metabo tropic glutamate receptor activation (Glaum and Miller, 1993) . In addition, an HO inhibitor reduced depolariza tion-induced glutamate release (Shinomura et aI., 1994) , although it did not influence glutamate release in tran sient forebrain ischemia (Takizawa et aI., 1996) . Thus, an increase in HO activity may produce divergent effects in cerebral ischemia and it has not yet been established whether induction of HO-l protein plays a protective role against cerebral ischemia. To evaluate the role of HO-l in cerebral ischemia, we investigated the effects of tin mesoporphyrin IX (SnMP), an inhibitor of HO activ ity, and ferriprotoporphyrin IX chloride (hemin), an HO inducer, on the pathologic outcome and on the immuno histochemical reaction for HO-l in rat transient forebrain ischemia.
MATERIALS AND METHODS

Transient forebrain ischemia model
The surgical and anesthetic procedures were approved by the Animal Experimentation Committee, School of Medicine, Tokai University.
The experiments were performed on 26 male Wistar rats (Clea Japan Co. Ltd., Tokyo) weighing approximately 350 g.
Animals were fasted overnight but allowed free access to water.
Transient forebrain ischemia was achieved by using the four vessel occlusion method (Pulsinelli and Brierley, 1979) with some modification (Chen et aI., 1997) . Briefly, on the day before the experiment, after induction of anesthesia with 2.5% halothane, both vertebral arteries were permanently occluded by electrocautery through the alar foramina of the first cervical vertebrae. Both carotid arteries were isolated through a midline neck incision, silk ligatures were placed loosely around them and the wound was closed with surgical clips. All skin wounds were instilled with 1 % xylocaine and food was withheld over night as the animals recovered from anesthesia. On the day of the experiment, under 2.0% halothane anesthesia with a mix ture of 30% oxygen and 70% nitrous oxide, the tail artery was exposed and catheterized with polyethylene tubing (PE-50) to allow blood sampling and continuous monitoring of arterial blood pressure. A thermocouple probe (52KJJ thermometer; John Fluke Mfg. Co., Everett, W A) was placed in the temporal muscles, and bipolar EEG electrodes were also inserted into the temporal muscles. Three minutes before carotid occlusions, the anesthesia was discontinued. After local infiltration of the neck with xylocaine, both common carotid arteries were lifted using the silk ligatures previously placed around them and occluded for 20 minutes with micro-aneurysm clips (Sugita clip #07-940-12, Mizuho Ika Co., Ltd., Japan). We confirmed that the EEG activity became isoelectric in all rats studied within 10 seconds after carotid occlusions. At the end of 20-minute oc clusion, the clips were released and restoration of carotid flow was confirmed by direct observation of the carotid arteries. Just after the start of recirculation, drugs as mentioned below were administered intraperitoneally. During the experiment, tempo ral muscle and rectal temperatures were controlled at about 37°C with an external heating lamp and a heating pad, respec tively. These temperatures and the MABP were continuously monitored. Arterial gases and blood glucose level were exam ined before ischemia, at 5 minutes after carotid occlusions and 30 minutes after the start of recirculation. Hematocrit was ex amined before ischemia. At the end of the surgery, all wounds were sutured, the arterial catheter was removed, and rats were allowed free access to water and food.
Three days later, the animals were re-anesthetized with 4% halothane, and killed by transabdominal-arterial perfusion fixa tion with 100 mL of phosphate-buffered saline, followed by 100 mL of 4% paraformaldehyde in 0.01 mollL phosphate buffer. The brain was carefully removed from the skull and stored in 4% paraformaldehyde in 0.01 mollL phosphate buffer (pH 7.4) for 24 hours. Coronal brain sections were obtained at J Cereb Blood Flow Metab. Vol. 18. No.5, 1998 20-fJ,m intervals and stained with hematoxylin and eosin, as well as HO-I glial fibrillary acidic protein and tubulin by im munohistochemical techniques, as described below.
Experimental design
Animals were divided into four experimental groups. Groups 1, 2, and 3 were exposed to forebrain ischemia as described 
Histologic examinations
Hematoxylin and eosin staining was performed in all sec tions obtained. Simultaneously, using consecutive sections, im munohistochemical staining for HO-I, glial fibrillary acidic protein (GFAP), and tubulin was performed using indirect im munohistochemical staining methods. Briefly, after removal of the paraffin, the coronal brain sections were incubated in a 5-mmollL solution of hydrogen peroxide for 10 minutes to oxidize pseudoperoxidase compounds and exposed to 5% nor mal goat serum for 10 minutes. The sections were first incu bated with rabbit anti-rat HO-I (Stress Gen, Victoria, BC, Canada) at 1000-fold dilution, mouse monoclonal anti-GFAP (Amersham, England) at 200-fold dilution, and mouse mono clonal anti-rat tubulin (Amersham, England) at 400-fold dilu tion for 3 hours in a humidified chamber at 4°C. After having been washed thoroughly with 0.01 mollL of sodium phosphate buffered saline (pH 7.2), the sections were incubated with don key anti-rabbit immunoglobulin G (ab ' h at 20-fold dilution (for HO-l), or sheep anti-mouse immunoglobulin G F(ab ' h at 20-fold dilution (for GFAP or tubulin) for 1 hour. The bound antibody was visualized with 3,3 ' -diaminobenzidine and hy drogen peroxide (Graham and Karnovsky, 1966) .
The ischemic damage within the hippocampus CA I and CA3
regions was quantitated by one observer (H. H.), who was blinded to the experimental protocol, by counting numbers of normal-appearing pyramidal neurons per high-power field (400x) at three levels of the hippocampus, along a predeter mined number of grid lengths (-300 fJ,m), Numbers of normal appearing neurons were also quantitated by counting cells in layers III and IV of the neocortex centered at -2 mm dorsal to the entorhinal fissure (400x) and in the dorsolateral striatum (400x). Viable neurons were defined as those cells showing a distinct nucleus and nucleolus (Dietrich et aI., 1995) .
The immunohistochemical staining for HO-l was evaluated using the semiquantitative scale of Zhang et al. (1993) with some modification. The percentages of HO-l-positive cells among all cells were graded as follows: <2% = 0; 2% to 50% = I; >51 % = 2. This evaluation was also performed by an observer who was blinded to the experimental protocol.
Statistical analysis
The statistical significance of differences in viable cell count and physiologic parameters among the four groups was ana lyzed by means of one-way analysis of variance followed by Fisher's protected least significant difference, The statistical significance of differences in the score of HO-l immunoreac tivity among the four groups was analyzed by use of the Kruskal-Wallis test followed by Dunn's procedure. All values were expressed as mean ± SD.
RESULTS
Mean arterial blood pressure, brain and rectal tempera tures, arterial blood gases, and blood glucose and hemat ocrit levels in the four groups are shown in Table 1 . There were no statistically significant changes among the four groups.
In sham-operated animals, no ischemic cell damage and no reaction for HO-I were observed in the CA 1 hippocampus ( Fig. IA and IB) , the CA2 hippocampus ( Fig. 2A and 2B ), the parietal cortex ( Fig. 3A and 3B ), and the striatum ( Fig. 4A and 4B ). None of the tissue sections studied showed any reaction to normal rabbit serum used as an immunologic negative control. Figure I shows representative photomicrographs of hematoxylin and eosin staining and immunohistochemi cal staining for HO-I in the CAl hippocampus. In the animals subjected to four-vessel occlusion and treated with saline alone, most of the pyramidal neurons showed ischemic cell damage, characterized by shrunken, darkly stained cytoplasm and pyknotic nuclei, with accumula tion of glial cells (Fig. IC) . These findings were con firmed by GFAP and tubulin stainings (not shown). In a consecutive section, no immunohistochemical reaction for HO-I was seen in neurons or glia (Fig. ID) . In the animals subjected to occlusion and treated with SnMP ( Fig. IE and F) or hemin ( Fig. I G and H) , ischemic changes were seen in most of the neurons and no immu nohistochemical reaction for HO-I was observed in the CA I hippocampus; these findings are similar to those in the saline-treated animals. Figure 2 shows representative photomicrographs in the CA3 hippocampus. In the animals subjected to oc clusion and treated with saline ( Fig. 2C) or SnMP ( Fig.  2E) , the majority of the neurons were damaged and glial cells had proliferated. In consecutive sections, a few HO I-positive cells were observed (Fig. 2D ). In the animals subjected to occlusion and treated with hemin, many neurons were swollen or shrunk, but the destruction of CA3 pyramidal cells was not complete (Fig. 2G) . A few of HO-I-positive cells were observed (Fig. 2H) . Figure 3 shows representative photomicrographs in the parietal cortex. In the animals subjected to occlusion and treated with saline alone, most of the neurons were damaged (Fig. 3C ) and a strongly positive reaction for HO-I was observed predominantly in glia and partly in neurons (Fig. 3D) . However, the positive reaction for HO-I was reduced by treatment with SnMP ( Fig. 3F) , although the degree of ischemic neuronal damage was unchanged (Fig. 3E ). Furthermore, treatment with hemin 1 hippocampus (600x) . In a sham-operated animal, no ischemic cell damage (A) and no reaction for heme oxygenase-1 (HO-1) (8) were observed. In an animal subjected to four-vessel occlusion and treated with saline, most of the pyramidal neurons showed ischemic cell damage and the glial cells had proliferated (arrows in C), while no reaction for HO-1 was observed (0). In an animal subjected to occlusion and treated with SnMP (E, F) or hemin (G, H), severe ischemic changes in most of the neurons and no reaction for HO-1 were observed in the CA1 hippocampus. Scale bar = 40 IJm.
Hematoxylin and eosin staining HO-l immunoreactivity FIG. 2. Histopathologic findings in the CA3 hippocampus (600x). In a sham-operated animal, no ischemic cell damage (A) and no reaction for heme oxygenase-1 (HO-1) (8) were observed. In an animal subjected to occlusion and treated with saline (C) or SnMP (E), the majority of the neurons were damaged and glial cells had proliferated (arrows). In a consecutive section, a few HO-1-positive cells were observed (arrowheads in 0). In an animal subjected to occlusion and treated with hemin, moderate neuronal damage (G) and a few HO-1-positive cells (arrowheads in H) were observed.
Hematoxylin and eosin staining HO-l immunoreactivity FIG. 3. Histopathologic findings in the parietal cortex (600x). In a sham-operated animal, no ischemic cell damage (A) and no reaction for heme oxygenase-1 (HO-1) (8) were observed. In an animal subjected to occlusion and treated with saline, most of the neurons were damaged (e), glial cells had proliferated (arrows), and a strongly positive reaction for HO-1 (arrowheads) was observed in both neurons and glia (D). The positive reaction for HO-1 was reduced by treatment with tin mesoporphyrin (F), although the degree of ischemic neuronal damage was unchanged (E). Treatment with hemin increased both surviving neurons (G) and HO-1 immunoreactivity in neurons and glia (arrowheads in H). (600x) . In a sham-operated animal, no ischemic cell damage (A) and no reaction for heme oxygenase-1 (HO-1) (8) were observed. In an animal subjected to occlusion and treated with saline, half of the neurons were damaged (C) accompanied with glial proliferation (arrows) and a strongly positive reaction for HO-1 was observed in both neurons and glia (arrowheads in 0). Treatment with tin mesoporphyrin reduced the number of surviving neurons (E) and the HO-1 immunoreactivity (F).
Treatment with hemin increased the number of surviving neurons (G) and the HO-1 immunoreactivity in neurons and glia (arrowheads in H). Quantitative cell counts of normal-appearing neurons and semiquantitative scores of immunohistochemical reaction for heme oxygenase-1 in all regions for the four experimental groups (mean ± SO). Significant difference from the sham-operated group at P < .05* and P < .01 **; @Significant difference from the saline-treated group at P < .01; #Significant difference from the saline-treated group at P< .05.
increased surviving neurons and HO-I immunoreactivity in neurons and glia ( Fig. 3G and H) . Figure 4 shows representative photomicrographs in the striatum. In the animals subjected to occlusion and treated with saline alone, half of the neurons were dam aged (Fig. 4C ) and a strongly positive reaction for HO-I was observed predominantly in glia and partly in neurons (Fig. 4D) . Treatment with SnMP reduced the number of surviving neurons, although a few HO-I-positive cells were observed ( Fig. 4E and F) . Treatment with hemin, however, increased both the surviving neurons and HO-l immunoreactivity in neurons and glia ( Fig. 4G and H) . Figure S shows quantitative cell counts of normal appearing neurons and the semiquantitative cell counts of normal-appearing neurons and the semiquantitative scores of immunohistochemical reaction for HO-I in the CAl and CA3 hippocampi, the parietal cortex, and the striatum for all experimental groups. In the CAl hippo-J Cereb Blood Flow Metab. Vol. 18, No. 5, 1998 campus, forebrain ischemia treated with saline, SnMP, and hemin significantly reduced normal-appearing neu rons compared to those in the sham-operated control, but there was no significant difference in cell counts among the former three groups (Fig. SA) . There was no signifi cant difference in the scores of HO-I immunoreactivity among the four groups, although a weak reactivity was seen in every ischemia group (Fig. SB) . In the CA3 hip pocampus, forebrain ischemia treated with saline, SnMP, and hemin reduced viable neurons to 34.8% (P < .OS), SO.3% and 73.9% of sham-operated control values, re spectively (Fig. SC) , but there was no significant differ ence in the scores of HO-1 immunoreactivity among the four groups (Fig. SD) . In the parietal cortex ( Fig. 5E and  F) , forebrain ischemia treated with saline and SnMP sig nificantly reduced viable neurons to 50.6% and 42.1 % of sham-operated control values (P < .01 ), and increased the scores of HO-I immunoreactivity to 1.5 ± 0.5 (P < .05 from the sham-operated control) and 1.1 ± 0.7 (not significant), respectively. However, hemin significantly increased the viable neurons in the cortex compared to the SnMP-treated group (P < .05), and significantly in creased the score of HO-l immunoreactivity compared to the sham-operated group (P < .05). In the striatum (Fig. 5G and H) , forebrain ischemia treated with saline and SnMP led to a decrease of viable neurons (P < .01 from the sham-operated group) and increased the scores of HO-l immunoreactivity to 1.7 ± 0.5 (P < .05 from the sham-operated control) and 1.1 ± 0.7 (not significant), respectively. Hemin, however, significantly increased vi able neurons compared to the saline (P < .01)-or SnMP (P < .05)-treated group, and significantly increased the score of HO-l immunoreactivity to 1.9 ± 0.4 (P < .05 from the sham-operated group).
DISCUSSION
The role of CO as a neural messenger has been docu mented (Verma et aI., 1993; Dawson and Synder, 1994) , but little is known about the influence of CO on cerebral ischemia. The main findings of this study were that he min, an HO inducer, led to a decrease in neuronal dam age in the cortex and striatum, concomitantly with posi tive HO-l immunoreactivity, at 3 days after forebrain ischemia, whereas the administration of SnMP, an HO inhibitor, tended to exacerbate the neuronal damage in the parietal cortex. In contrast, neither hemin nor SnMP affected the pathologic outcome in the CA J and CA3 hippocampi, and HO-I immunoreactivity in the CA 1 and CA3 hippocampi was weak. These results represent the first in vivo evidence that induction of HO-l protein may contribute to cellular defense against ischemic damage in brain regions where potential ability to synthesize HO-J is retained in cerebral ischemia. Conversely, if severe ischemia destroys the ability to synthesize HO-l protein, an HO inducer cannot be expected to have a neuropro tective effect. Similar tissue protection by an HO inducer against glycerol-induced acute renal failure (Nath et aI., 1992) and carrageenin-induced pleurisy (Willis et aI., 1996) has been reported. These findings, including ours, are consistent with the hypothesis that induction of HO protein may play a considerable role in tissue protection against oxidative stress in some parts of the brain, al though the possibility has not been ruled out that HO-l protein translocation may also be involved.
The mechanism of neuroprotection via an increase in HO activity is unclear. The presently proposed potential role of HO in cellular defense is consistent with its known catalytic action, i.e., production of bilirubin and biliverdin, which act as antioxidants (Stocker et aI., 1987a (Stocker et aI., , 1987b , and production of CO, which increases blood flow due to its vasodilating effect (Verma et aI., 1993) , inhibits some of the enzymes involved in arachi donic acid metabolism (Martasek et aI., 1991) , and binds heme moieties that can inactivate heme enzymes such as NOS (White and Marietta, 1992) . On the other hand, it has been reported that the HO inhibitor zinc protopor phyrin IX (ZnPP) reduced infarct size and edema accu mulation in focal ischemia (Kadoya et aI., 1995) , blocked the effect of metabotropic glutamate receptor activation (Glaum and Miller, 1993) , and reduced depolarization induced glutamate release (Shinomura et aI., 1994) . However, it has been pointed out that ZnPP inhibits both HO and NOS activities (Meffert et aI., 1994; Takizawa et aI., 1996) ; therefore, it is unlikely that the results ob tained with ZnPP reflect the inhibition of HO activity alone.
In cerebral ischemia, the expression of HO-I mRNA and the induction of HO-l protein immunoreactivity have been reported (Paschen et aI., 1994; Takeda et aI., 1994; Geddes et aI., 1996; Nimura et aI., 1996) . Inter estingly, the distribution and the time course of HO-l mRNA after forebrain ischemia observed by Paschen et al. (1994) are consistent with those of HO-1 protein in this study. After transient global ischemia followed by recirculation, the HO-l mRNA level increased consis tently up to 24 hours in the cortex and striatum, while it peaked at 4 hours (nine-fold over the control) and there after decreased to 4.5-fold over the control at 24 hours in the hippocampus. Because both heat shock and hemin induce HO at the transcriptional level (Shibahara et aI., 1987) , ischemic insult may also influence HO-l protein synthesis at the transcriptional level, in parallel with the intense induction of mRNA in the cortex and striatum and the poor induction of mRNA in the hippocampus (Paschen et aI., 1994) . In our model, HO-l protein was induced predominantly in glia and partly in neurons in layers III and IV of the neocortex and in the dorsolateral striatum 3 days after transient forebrain ischemia, but not in hippocampus. Geddes et ai. (1996) observed that HO-l immunoreactivity is evident in both neurons and glia in hippocampus, cerebral cortex and thalamus at 24 hours after a 20-minute four-vessel occlusion with hy potension in rats, and predominantly in astrocytes in J Cereb Blood Flow Metab. Vol. 18, No.5, 1998 CA3c and CAl of the hippocampus at 72 hours after global ischemia. It is conceivable that the degree of glial proliferation and the cell type showing positive HO-l immunoreactivity may be variable depending on the pe riod of reperfusion after ischemia, and the severity of the ischemia.
HO comprises two isozymes identified as HO-1 and HO-2 (Maines, et aI., 1986) . HO-l mRNA and protein are present in selected regions including hilar neurons in the hippocampus under normal conditions (Ewing, et aI., 1992) , but are increased in response to various insults including oxidative stress (Keyse and Tyrrell, 1989 ) and hyperthermia (Dawyer et aI., 1992; Ewing et aI., 1992) . On the other hand, HO-2 is a constitutively expressed isoform, which accounts for most of the HO activity in normal brain , and its immu noreactivity is not altered by transient global ischemia (Geddes et aI., 1996) . Although SnMP and hemin may modulate both HO-I and HO-2 activities, our immuno histochemical results may suggest that at least HO-1 con tributes to the neuroprotection against ischemic damage. It is unclear whether HO-2 also plays a protective role against ischemia because we did not examine the changes of HO-2 immunoreactivity.
In conclusion, the present results suggest that induc tion of HO-l protein by the administration of hemin may contribute to cellular defense against ischemic damage in some brain regions such as the parietal cortex and stria tum, where potential ability to synthesize HO-l may be retained in cerebral ischemia. Our finding, therefore, may suggest a new therapeutic strategy to increase the resistance of the ischemic brain to oxidative stress, al though this treatment cannot rescue severely damaged tissue, such as the CAl hippocampus in global ischemia.
